Evaluation Of Whole-Body Fdg-Pet Imaging For The Detection Of Metastaic Ovarian Tumors In Patients With Suspected Recurrence

Current diagnostic techniques, including computed tomography (CT), magnetic resonance imaging (MRI) and ultrasonography (US) are not efficient for the detection of metastatic tumors in gynecological malignancies. Recently, whole-body positron emission tomography (PET) has been taken for patients with cancer. This study assessed the diagnostic accuracy of whole-body FDG-PET for the detection of tumor foci in 44 patients with suspected metastatic lesions of ovarian malignancies in comparison of CT, MRI and US, including specific tumor makers. We concluded that FDG-PET scan had high sensitivity for detecting both intraperitoneal and retroperitoneal metastases (93% and 91%, respectively).